InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2021-07-27 00:00:00 ET · period of report 2021-07-22 · accession 0001213900-21-038789 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2021-07-27 2021-07-22 WGS Casdin Eli Dir C - Cnv Deriv $0.00 +10.99M 10.99M New $0
DI 2021-07-27 2021-07-22 WGS Casdin Eli Dir A - Grant $0.00 +5.00M 5.00M New $0
DI 2021-07-27 2021-07-22 WGS Casdin Eli Dir A - Grant — +6.74M 6.74M New —
DI 2021-07-27 2021-07-22 WGS Casdin Eli Dir C - Cnv Deriv $0.00 -10.99M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-07-22 C A 10,993,750 $0.00 10,993,750 I By CMLS Holdings LLC — — (F2) The securities are held of record by CMLS Holdings LLC ("CMLS Holdings"). CMLS Holdings LLC is the record holder of the Class A common stock and the Class A Common Stock exercisable upon the issuance of warrants reported herein. The Board of Managers of CMLS Holdings LLC is comprised of Mr. Casdin and Mr. Keith Meister who share voting and investment discretion with respect to the Class A common stock held of record by CMLS Holdings LLC. C-LSH LLC and M-LSH LLC are the members of CMLS Holdings LLC, and Messrs. Casdin and Meister are the managing members of C-LSH LLC and M-LSH LLC, respectively. As such, Mr. Casdin may be deemed to have or share beneficial ownership of the securities held directly by CMLS Holdings LLC. Each of C-LSH LLC and Mr. Casdin disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.
2 Common Class A Common Stock 2021-07-22 A A 5,000,000 $0.00 5,000,000 I Casdin Partners Master Fund, LP — — (F3) The securities reflected as beneficially owned by Casdin Partners Master Fund, LP in the table above consists of 5,000,000 shares of Class A common stock. Such securities are owned directly by Casdin Partners Master Fund, LP and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, LP, (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (iii) Mr. Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Each of Casdin Capital, LLC, Casdin Partners GP, LLC and Mr. Casdin disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein.
3 Derivative Warrants to purchase Class A Common Stock (right to buy) 2021-07-22 A A 6,736,669 — 6,736,669 I By CMLS Holdings LLC $11.50 · 2021-09-05 to 2027-09-05 6,736,669 Class A Common Stock (F4) Following the completion of the business combination, warrants to purchase Class A Common Stock become exercisable on September 5, 2021, the date that is one year after the closing of the IPO of Sema4's predecessor, CMLS. (F2) The securities are held of record by CMLS Holdings LLC ("CMLS Holdings"). CMLS Holdings LLC is the record holder of the Class A common stock and the Class A Common Stock exercisable upon the issuance of warrants reported herein. The Board of Managers of CMLS Holdings LLC is comprised of Mr. Casdin and Mr. Keith Meister who share voting and investment discretion with respect to the Class A common stock held of record by CMLS Holdings LLC. C-LSH LLC and M-LSH LLC are the members of CMLS Holdings LLC, and Messrs. Casdin and Meister are the managing members of C-LSH LLC and M-LSH LLC, respectively. As such, Mr. Casdin may be deemed to have or share beneficial ownership of the securities held directly by CMLS Holdings LLC. Each of C-LSH LLC and Mr. Casdin disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. (F1) In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as CM Life Sciences, Inc. or "CMLS") and Mount Sinai Genomics, Inc. d/b/a Sema4 ("Sema4"), among other things, each share of CMLS's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis.
4 Derivative Class B Common Stock 2021-07-22 C D 10,993,750 $0.00 0 I By CMLS Holdings LLC — · — to — 10,993,750 Class A Common Stock (F2) The securities are held of record by CMLS Holdings LLC ("CMLS Holdings"). CMLS Holdings LLC is the record holder of the Class A common stock and the Class A Common Stock exercisable upon the issuance of warrants reported herein. The Board of Managers of CMLS Holdings LLC is comprised of Mr. Casdin and Mr. Keith Meister who share voting and investment discretion with respect to the Class A common stock held of record by CMLS Holdings LLC. C-LSH LLC and M-LSH LLC are the members of CMLS Holdings LLC, and Messrs. Casdin and Meister are the managing members of C-LSH LLC and M-LSH LLC, respectively. As such, Mr. Casdin may be deemed to have or share beneficial ownership of the securities held directly by CMLS Holdings LLC. Each of C-LSH LLC and Mr. Casdin disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. (F1) In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as CM Life Sciences, Inc. or "CMLS") and Mount Sinai Genomics, Inc. d/b/a Sema4 ("Sema4"), among other things, each share of CMLS's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis.